Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Faculty Members have conducted research related to the Mechanistic Approach for Protective Effect of Ara290, a Specific Ligand for the Erythropoietin/Cd131 Heteroreceptor, Against Cisplatin-Induced Nephrotoxicity, the Involvement of Apoptosis and Inflammation Pathways
Maryam Taghizadeh-Ghehi
Maryam Taghizadeh-Ghehi

Assistant Professor of Clinical Pharmacy

Research Center for Rational Use of Drugs

Tehran University of Medical Sciences

All Documents
1. Effects of Hypertonic Sodium Lactate on Intracranial Pressure in Patients With Traumatic Brain Injury: A Systematic Review and Meta-Analysis on Clinical Trial Studies, Basic and Clinical Neuroscience (2024)
2. A Nationwide Study on Consumption of Opioid Analgesics in Iran From 2000 to 2018, International Journal of Clinical Pharmacy (2023)
3. A Recent Clinical Trial on Efficacy of Citalopram to Prevent Stroke Recurrence: Unresolved Controversies, Journal of Clinical Neuroscience (2023)
4. Comment on “Effect of Imatinib Treatment on Renal Anemia in Chronic Myeloid Leukemia Patients”, Journal of Oncology Pharmacy Practice (2023)
5. Ginkgo Biloba Efficacy in the Treatment of Drug-Induced Parkinsonism: A Randomized Clinical Trial, Iranian Journal of Pharmaceutical Research (2023)
6. Physicians’ Compliance With Order Entry Forms for Intravenous Pantoprazole in a Tertiary Care Hospital, Acta Medica Iranica (2023)
7. Adverse Drug Reactions of Rituximab in Patients Suffering From Autoimmune Neurological Diseases, DARU# Journal of Pharmaceutical Sciences (2022)
8. A Comparative Study Between Non‑Colistin Based Combinations for Treatment of Infections Caused by Extensive Drug Resistant Acinetobacter Baumannii: Comments, International Journal of Clinical Pharmacy (2021)
9. Are Adverse Drug Reactions to Anti-Diabetic Drugs More Common in Patients Whose Treatment Do Not Adhere to Diabetes Management Clinical Guidelines? Comments on a Study Report, European Journal of Clinical Pharmacology (2021)
10. Is Cinnarizine/Betahistine Combination Superior to Respective Monotherapies in Treatment of Vertigo? Comment on a Randomized Triple-Blind Placebo-Controlled Trial, European Journal of Clinical Pharmacology (2020)
11. Comment on “Retrospective Study of Hypersensitivity Reactions to Chemotherapeutic Agents in a Thoracic Oncology Service”, Journal of Clinical Pharmacy and Therapeutics (2019)
12. Cost-Effectiveness Analysis of Low Versus High Dose Colistin in the Treatment of Multi-Drug Resistant Pneumonia: A Comment, International Journal of Clinical Pharmacy (2019)
13. Adherence to Medications, Self-Care Activity, and Hba1c Status Among Patients With Type 2 Diabetes Living in an Urban Area of Iran, Journal of Diabetes and Metabolic Disorders (2018)
14. Comment on ‘Clinical Impact of Non-Antibiotic Recommendations by a Multi-Disciplinary Antimicrobial Stewardship Team’, International Journal of Antimicrobial Agents (2018)
15. Comments on “Strategies for Reduction in the Duration of Intravenous Drug Use: Interest of Drug Tracers As Quality Indicators to Improve Intravenous to Oral Switch”, Journal of Evaluation in Clinical Practice (2018)
16. Effect of Hospital-Wide Interventions to Optimize Albumin Use in a Tertiary Hospital, Journal of Clinical Pharmacy and Therapeutics (2017)
17. Vancomycin-Induced Thrombocytopenia: A Narrative Review, Drug Safety (2017)
18. A Double-Blind, Randomized, Controlled Trial on N-Acetylcysteine for the Prevention of Acute Kidney Injury in Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation, Hematological Oncology (2015)
19. Urine Neutrophil Gelatinase Associated Lipocalin As an Early Marker of Acute Kidney Injury in Hematopoietic Stem Cell Transplantation Patients, Renal Failure (2015)
20. N-Acetyl Cysteine for Prevention of Oral Mucositis in Hematopoietic Sct: A Double-Blind, Randomized, Placebo-Controlled Trial, Bone Marrow Transplantation (2014)